EpoetinBetaQualityChecker
Epoetin Beta
Epoetin Beta Quality Checker — Biologic Drug (Erythropoietin Beta) (Ph. Eur., USP, ICH Q6B)
ℹ️ The utility checks specific activity, aggregates (PRCA risk), high sialylation, HCP, DNA, sterility.
ℹ️ Does not use machine learning — rule-based logic only.
⚠️ CRITICAL! Aggregates ≤2%, Activity 80k-120k IU/mg, Acidic Variants 45-75%, Sterility!
Usage:
EpoetinBetaQualityChecker.exe → demo mode
EpoetinBetaQualityChecker.exe input.csv output.json → evaluate data
Input format:
BatchNumber,Protein_Concentration_mgPerMl,Specific_Activity_IU_per_mg,Total_Potency_IU_per_ml,pH_Value,Osmolality_mOsm_kg,Aggregate_Percent_SEC,Fragment_Percent_SEC,Acidic_Variants_Percent_IEC,Basic_Variants_Percent_IEC,Main_Peak_Percent_IEC,Host_Cell_Protein_ppm,Residual_DNA_ngPerMl,Subvisible_Particles_2_10_um,Subvisible_Particles_10_25_um,Subvisible_Particles_gt_25_um,SterilityTest,Endotoxin_EU_ml
Example:
EPO-BETA-2026-001,1.0,98000,4000,6.6,295,0.7,0.4,60.0,8.0,32.0,35,1.8,2800,320,10,0,0.02
— WHY IS THIS NEEDED?
Epoetin beta — recombinant human erythropoietin (produced in CHO cells):
• Differs from alfa-form by higher sialic acid content (higher % of acidic variants), providing slightly longer half-life.
• Specific Activity (IU/mg): Key efficacy parameter. Determined by bioassay.
• Aggregates (HMW): Critical safety parameter. Risk of Pure Red Cell Aplasia (PRCA) if aggregates present.
• Glycosylation (Acidic Variants): Beta form characterized by shift towards more acidic isoforms (45-75%). Low value may indicate manufacturing issue or instability.
• Process Impurities: HCP and DNA must be removed to trace levels.
• Sterility and Endotoxins: Absolutely mandatory.
⚠️ CRITICAL:
• Specific Activity: 80,000 – 120,000 IU/mg
• Aggregates: ≤ 2.0% (strict limit due to PRCA risk)
• Acidic Variants (IEC): 45–75% (indicator of high sialylation typical for Beta)
• HCP: ≤ 100 ppm
• DNA: ≤ 10 ng/mL
• Sterility and Endotoxins: Mandatory
• Particles >25 µm: ≤ 60 counts/mL
⚠️ Note: Utility adapted for epoetin beta specifics, setting higher lower limits for acidic variants compared to alfa-form. Aggregate control remains priority #1. Glycosylation profile directly affects pharmacokinetics: insufficient sialylation leads to rapid clearance and lack of therapeutic effect in anemic patient.
input.csv
BatchNumber,Protein_Concentration_mgPerMl,Specific_Activity_IU_per_mg,Total_Potency_IU_per_ml,pH_Value,Osmolality_mOsm_kg,Aggregate_Percent_SEC,Fragment_Percent_SEC,Acidic_Variants_Percent_IEC,Basic_Variants_Percent_IEC,Main_Peak_Percent_IEC,Host_Cell_Protein_ppm,Residual_DNA_ngPerMl,Subvisible_Particles_2_10_um,Subvisible_Particles_10_25_um,Subvisible_Particles_gt_25_um,SterilityTest,Endotoxin_EU_ml EPO-BETA-2026-001,1.0,98000,4000,6.6,295,0.7,0.4,60.0,8.0,32.0,35,1.8,2800,320,10,0,0.02
URS & FS — user requirements and functional specification
This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.
1. Scope
The Epoetin Beta Quality Checker utility is used for Epoetin Beta. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.
The utility does not use machine learning; decisions are produced by deterministic rules.
Categories: Global API
Tags: API, assay, biologics, biosimilars, endotoxins, fixed-dose combinations, generics, impurities, market map, sterility
2. Execution modes
EpoetinBetaQualityChecker.exe → demo mode EpoetinBetaQualityChecker.exe input.csv output.json → evaluate data
3. Key controlled areas
- assay / content
- microbiology and pathogens
- pH and physicochemical parameters
- activity, decay and radiochemical purity
4. Domain limits and critical parameters
- ⚠️ CRITICAL! Aggregates ≤2%, Activity 80k-120k IU/mg, Acidic Variants 45-75%, Sterility!
- ⚠️ CRITICAL:
- Specific Activity: 80,000 – 120,000 IU/mg
- Aggregates: ≤ 2.0% (strict limit due to PRCA risk)
- Acidic Variants (IEC): 45–75% (indicator of high sialylation typical for Beta)
- HCP: ≤ 100 ppm
- DNA: ≤ 10 ng/mL
- Sterility and Endotoxins: Mandatory
- Particles >25 µm: ≤ 60 counts/mL
- ⚠️ Note: Utility adapted for epoetin beta specifics, setting higher lower limits for acidic variants compared to alfa-form. Aggregate control remains priority #1. Glycosylation profile directly affects pharmacokinetics: insufficient sialylation leads to rapid clearance and lack of therapeutic effect in anemic patient.
5. URS — user requirements
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The system shall accept an input.csv file for Epoetin Beta with the exact columns listed in the “Input data contract” section. | High | A file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error. |
| URS-002 | The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data. | Medium | Both execution scenarios produce a predictable result or clear diagnostic error. |
| URS-003 | The system shall perform rule-based controls for: assay / content, microbiology and pathogens, pH and physicochemical parameters, activity, decay and radiochemical purity. | High | Each controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML. |
| URS-004 | The system shall preserve traceability between batch/lot, source values, applied rules and final verdict. | High | Output includes batch identifier, source values, parameter statuses and critical findings. |
| URS-005 | The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review. | High | JSON contains overall status, check array, warnings, failures and source-file reference. |
| URS-006 | The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks. | High | The document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval. |
| URS-007 | The system shall clearly separate technical data errors from specification nonconformities. | Medium | Schema/type errors are not mixed with pharmacopoeial deviations and are reported separately. |
6. input.csv data contract
The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.
| # | Column | Type | Unit | Description | Sample | Control rule |
|---|---|---|---|---|---|---|
| 1 | BatchNumber | identifier | as specified | Batch Number | EPO-BETA-2026-001 | mandatory field; used for batch/lot traceability |
| 2 | Protein_Concentration_mgPerMl | decimal | mg/ml | Protein Concentration mg per Ml | 1.0 | numeric value; compared with assay/purity limit from specification or method |
| 3 | Specific_Activity_IU_per_mg | decimal | as specified | Specific Activity IU per mg | 98000 | mandatory numeric value; rule comparison is performed by the utility |
| 4 | Total_Potency_IU_per_ml | decimal | IU/ml | Total Potency IU per ml | 4000 | mandatory numeric value; rule comparison is performed by the utility |
| 5 | pH_Value | decimal | pH | p H Value | 6.6 | mandatory numeric value; rule comparison is performed by the utility |
| 6 | Osmolality_mOsm_kg | decimal | mOsm/kg | Osmolality m Osm kg | 295 | mandatory numeric value; rule comparison is performed by the utility |
| 7 | Aggregate_Percent_SEC | decimal | % | Aggregate % SEC | 0.7 | mandatory numeric value; rule comparison is performed by the utility |
| 8 | Fragment_Percent_SEC | decimal | % | Fragment % SEC | 0.4 | mandatory numeric value; rule comparison is performed by the utility |
| 9 | Acidic_Variants_Percent_IEC | decimal | % | Acidic Variants % IEC | 60.0 | mandatory numeric value; rule comparison is performed by the utility |
| 10 | Basic_Variants_Percent_IEC | decimal | % | Basic Variants % IEC | 8.0 | mandatory numeric value; rule comparison is performed by the utility |
| 11 | Main_Peak_Percent_IEC | decimal | % | Main Peak % IEC | 32.0 | mandatory numeric value; rule comparison is performed by the utility |
| 12 | Host_Cell_Protein_ppm | decimal | ppm | Host Cell Protein ppm | 35 | mandatory numeric value; rule comparison is performed by the utility |
| 13 | Residual_DNA_ngPerMl | decimal | as specified | Residual DNA ng per Ml | 1.8 | mandatory numeric value; rule comparison is performed by the utility |
| 14 | Subvisible_Particles_2_10_um | decimal | µm | Subvisible Particles 2 10 um | 2800 | mandatory numeric value; rule comparison is performed by the utility |
| 15 | Subvisible_Particles_10_25_um | decimal | µm | Subvisible Particles 10 25 um | 320 | mandatory numeric value; rule comparison is performed by the utility |
| 16 | Subvisible_Particles_gt_25_um | decimal | µm | Subvisible Particles gt 25 um | 10 | mandatory numeric value; rule comparison is performed by the utility |
| 17 | SterilityTest | boolean / flag | 0/1 | Sterility Test | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 18 | Endotoxin_EU_ml | decimal | as specified | Endotoxin EU ml | 0.02 | numeric value; critical safety attribute compared with endotoxin limit |
CSV example
BatchNumber,Protein_Concentration_mgPerMl,Specific_Activity_IU_per_mg,Total_Potency_IU_per_ml,pH_Value,Osmolality_mOsm_kg,Aggregate_Percent_SEC,Fragment_Percent_SEC,Acidic_Variants_Percent_IEC,Basic_Variants_Percent_IEC,Main_Peak_Percent_IEC,Host_Cell_Protein_ppm,Residual_DNA_ngPerMl,Subvisible_Particles_2_10_um,Subvisible_Particles_10_25_um,Subvisible_Particles_gt_25_um,SterilityTest,Endotoxin_EU_ml EPO-BETA-2026-001,1.0,98000,4000,6.6,295,0.7,0.4,60.0,8.0,32.0,35,1.8,2800,320,10,0,0.02
7. FS — functional specification
| ID | Function | Implementation description |
|---|---|---|
| FS-001 | CLI entry point | The executable EpoetinBetaQualityChecker.exe supports demo mode and input.csv output.json processing mode. |
| FS-002 | CSV parser | The import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator. |
| FS-003 | Field conversion | Each column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag. |
| FS-004 | Domain rule engine | For Epoetin Beta, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check. |
| FS-005 | Criticality handling | Critical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS. |
| FS-006 | JSON writer | output.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages. |
| FS-007 | Integration contract | The CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service. |
| FS-008 | Error handling | Schema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS. |
8. output.json contract
The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.
{
"utility": "EpoetinBetaQualityChecker",
"api": "Epoetin Beta",
"batchNumber": "EPO-BETA-2026-001",
"overallStatus": "PASS|WARNING|FAIL",
"checkedAtUtc": "2026-05-18T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "EPO-BETA-2026-001",
"unit": "as specified",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Protein_Concentration_mgPerMl",
"value": "1.0",
"unit": "mg/ml",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Specific_Activity_IU_per_mg",
"value": "98000",
"unit": "as specified",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Total_Potency_IU_per_ml",
"value": "4000",
"unit": "IU/ml",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "pH_Value",
"value": "6.6",
"unit": "pH",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Osmolality_mOsm_kg",
"value": "295",
"unit": "mOsm/kg",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Aggregate_Percent_SEC",
"value": "0.7",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Fragment_Percent_SEC",
"value": "0.4",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": [],
"sourceFile": "input.csv"
}9. OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| TC-001 | Valid CSV with expected header and sample row | All rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail. |
| TC-002 | A mandatory input.csv column is missing | Import is rejected or the row receives FAIL with schema reference. |
| TC-003 | A numeric field contains text or a blank value | Type conversion error is recorded; the result is not hidden as PASS. |
| TC-004 | A parameter is outside specification or critical limit | Critical parameters produce FAIL; non-critical deviations produce WARNING according to the rule. |
| TC-005 | Positive pathogen/microbiological flag or microbiological limit excursion | Critical FAIL is produced with the offending parameter. |
| TC-008 | Incorrect activity, reference time or radiochemical purity | FAIL/WARNING is produced with calculation traceability. |
10. QA/QC, CSV and change control
- Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
- Column names must not be changed without updating the validator and test scenarios.
- The source CSV, output.json and utility version should be stored together as an evidence package.
- Any change in control rules must go through change control and repeated OQ scenario verification.
Included in packages
Biopharmaceuticals Core QC Suite
Focused QC utility package for biologic products: HCP, mAbs, biosimilars, proteins/peptides, sterility, endotoxins and key release checks.
OpenBiopharmaceuticals Extended QC Suite
Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.
OpenGlobal API & Biosimilars QC Suite
Package for high-demand global APIs, generics and biosimilars, including fixed-dose combinations and biological products.
OpenImmunology QC Suite
QC utility package for immunology: monoclonal antibodies, biosimilars, immunomodulators, immunosuppressants, ELISA/SPR, HCP, protein characterization, sterility and pyrogen/release checks.
Open